[18F]AV‐1451 clustering of entorhinal and cortical uptake in Alzheimer's disease
暂无分享,去创建一个
David T. Jones | Anthony J. Spychalla | C. Jack | R. Petersen | J. Graff‐Radford | B. Boeve | M. Senjem | D. Knopman | V. Lowe | S. Weigand | C. Schwarz | J. Whitwell | N. Ertekin-Taner | K. Josephs | M. Machulda | D. Drubach | N. Tosakulwong | A. Spychalla | Nirubol Tosakulwong | D. Knopman
[1] Hanna Cho,et al. Off-Target 18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation , 2018, The Journal of Nuclear Medicine.
[2] Christopher G Schwarz,et al. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. , 2018, Brain : a journal of neurology.
[3] M. Mintun,et al. Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects , 2017, The Journal of Nuclear Medicine.
[4] A. Dale,et al. Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology , 2017, American Journal of Neuroradiology.
[5] Camille Roth,et al. Natural Scales in Geographical Patterns , 2017, Scientific Reports.
[6] Keith A. Johnson,et al. Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease , 2017, JAMA neurology.
[7] J. Graff‐Radford,et al. 18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies , 2017, The Journal of Nuclear Medicine.
[8] Nick C. Fox,et al. Consensus classification of posterior cortical atrophy , 2017, Alzheimer's & Dementia.
[9] David T. Jones,et al. Defining imaging biomarker cut points for brain aging and Alzheimer's disease , 2017, Alzheimer's & Dementia.
[10] Anthony J. Spychalla,et al. [18F]AV‐1451 tau positron emission tomography in progressive supranuclear palsy , 2017, Movement disorders : official journal of the Movement Disorder Society.
[11] B. Dickerson,et al. PART II. State of the Field: Advances in Neuroimaging from the 2016 Alzheimer’s Imaging Consortium Alzheimer’s disease: The influence of age on clinical heterogeneity through the human brain connectome , 2017 .
[12] Nick C Fox,et al. Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias , 2016, Alzheimer's & Dementia.
[13] W. Klunk,et al. [F‐18]AV‐1451 positron emission tomography retention in choroid plexus: More than “off‐target” binding , 2016, Annals of neurology.
[14] Nick C. Fox,et al. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease , 2016, Alzheimer's & Dementia.
[15] Clifford R. Jack,et al. An autoradiographic evaluation of AV-1451 Tau PET in dementia , 2016, Acta Neuropathologica Communications.
[16] C. Jack,et al. A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity , 2016, NeuroImage: Clinical.
[17] Jorge Sepulcre,et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease , 2016, Annals of neurology.
[18] Keith A. Johnson,et al. Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue , 2015, Annals of neurology.
[19] Frederik Barkhof,et al. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. , 2015, Brain : a journal of neurology.
[20] M. Cugmas,et al. On comparing partitions , 2015 .
[21] Daniel R. Schonhaut,et al. Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy , 2015, Annals of neurology.
[22] C. Jack,et al. APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia , 2014, Alzheimer's & Dementia.
[23] Nick C Fox,et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.
[24] Nilüfer Ertekin-Taner,et al. Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD , 2014, Neurology.
[25] C. Jack,et al. Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer’s disease presenting as logopenic progressive aphasia , 2013, Brain and Language.
[26] H. Kolb,et al. [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease , 2013, Alzheimer's & Dementia.
[27] Frederik Barkhof,et al. Different patterns of gray matter atrophy in early- and late-onset Alzheimer’s disease , 2013, Neurobiology of Aging.
[28] Clifford R. Jack,et al. FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer’s Type , 2013, PloS one.
[29] Min-Ying Su,et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. , 2013, Journal of Alzheimer's disease : JAD.
[30] Matthew L Senjem,et al. Indicators of amyloid burden in a population-based study of cognitively normal elderly , 2012, Neurology.
[31] C. Jack,et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study , 2012, The Lancet Neurology.
[32] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[33] R. Petersen,et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.
[34] J. Molinuevo,et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease , 2011, Neurology.
[35] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[36] Nick C Fox,et al. Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele , 2011, The Lancet Neurology.
[37] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[38] Charles Duyckaerts,et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.
[39] Friedrich Leisch,et al. Evaluation of structure and reproducibility of cluster solutions using the bootstrap , 2010 .
[40] C. Jack,et al. MRI correlates of neurofibrillary tangle pathology at autopsy , 2008, Neurology.
[41] C. Jack,et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.
[42] V. Pankratz,et al. The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics , 2008, Neuroepidemiology.
[43] Brian B. Avants,et al. Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain , 2008, Medical Image Anal..
[44] C. Jack,et al. Imaging correlates of posterior cortical atrophy , 2007, Neurobiology of Aging.
[45] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[46] K. Ishii,et al. Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of z score images. , 2005, AJNR. American journal of neuroradiology.
[47] G. Frisoni,et al. Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[48] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[49] M. Greicius,et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.
[50] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[51] William M. Rand,et al. Objective Criteria for the Evaluation of Clustering Methods , 1971 .